BioNexus Gene Lab Corp Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 13.55%44.02%15.10%16.96%11.52%13.61%13.56%
EBT Margin 28.21%-217.17%11.08%7.80%-2.78%-26.69%-16.77%
EBIT Margin 28.21%-217.17%11.18%7.90%-2.66%-26.54%-16.55%
EBITDA Margin -6.86%-186.36%10.93%3.87%-6.08%-29.65%-15.52%
Operating Margin 28.21%-217.17%11.18%7.90%-2.66%-26.54%-16.55%
Net Margin 43.96%-236.67%9.59%9.98%-2.30%-26.91%-16.81%
FCF Margin -110.42%-181.24%1.15%0.04%4.55%-20.18%-25.88%
Efficiency
Inventory Average 0.01M0.59M1.35M1.25M1.06M1.26M
Assets Average 1.44M5.67M9.84M9.16M10.07M10.92M
Equity Average 1.32M3.89M6.92M6.92M8.16M8.99M
Invested Capital 1.60M1.19M6.72M7.21M6.67M9.66M8.32M
Asset Utilization Ratio 0.092.011.361.190.970.87
Leverage & Solvency
Interest Coverage Ratio -112.60-81.3923.33-186.20-74.42
Equity Ratio 0.920.910.660.750.760.850.80
Times Interest Earned -112.60-81.3923.33-186.20-74.42
Dividends & Payouts
FCF Payout Ratio 0.020.00
Valuation
Enterprise Value -1.26M-0.86M-2.79M-2.12M-2.12M4.85M-0.66M
Market Capitalization 9.36M5.03M
Return Ratios
Return on Sales 0.44%-2.37%0.10%0.10%-0.02%-0.26%-0.17%
Return on Capital Employed -0.20%0.55%0.14%-0.04%-0.31%-0.18%
Return on Invested Capital 0.28%-0.03%-0.32%-0.17%
Return on Assets -0.21%0.19%0.14%-0.03%-0.26%-0.15%
Return on Equity -0.23%0.28%0.19%-0.04%-0.32%-0.18%